Resultados da busca - Ma, Jianyong
- Mostrando 1 - 20 resultados de 41
- Ir para a próxima página
-
1
-
2
-
3
Rapid Responses and Mechanism of Action for Low-Dose Bisphenol S on ex Vivo Rat Hearts and Isolated Myocytes: Evidence of Female-Specific Proarrhythmic Effects por Gao, Xiaoqian, Ma, Jianyong, Chen, Yamei, Wang, Hong-Sheng
Publicado em 2015Texto -
4
-
5
-
6
Does subclinical atrial fibrillation independently predict adverse outcomes in patients with heart failure and cardiac resynchronization therapy defibrillator por Chen, Jie, Yu, Peng, Ma, Jianyong, Zheng, Chunhua, Liu, Xiao
Publicado em 2021Texto -
7
-
8
-
9
-
10
Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation: A PRISMA-compliant article por Zeng, Junquan, Yu, Peng, Cui, Wenjuan, Wang, Xiaoping, Ma, Jianyong, Zeng, Changai
Publicado em 2020Texto -
11
The role of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A PRISMA-compliant article por Liu, Xuyang, Huang, Manxiang, Ye, Caisheng, Zeng, Junquan, Zeng, Changai, Ma, Jianyong
Publicado em 2020Texto -
12
Meta-analysis of the efficacy and safety of non-vitamin K antagonist oral anticoagulants with warfarin in Latin American patients with atrial fibrillation por Su, Zhiyu, Zhang, Hao, He, Wenfeng, Ma, Jianyong, Zeng, Junquan, Jiang, Xinhua
Publicado em 2020Texto -
13
Effectiveness and Safety of DOACs vs. Warfarin in Patients With Atrial Fibrillation and Frailty: A Systematic Review and Meta-Analysis por Zeng, Shan, Zheng, Yuxiang, Jiang, Jingzhou, Ma, Jianyong, Zhu, Wengen, Cai, Xingming
Publicado em 2022Texto -
14
-
15
Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID‐19, inflammation level, severity, and death in patients with COVID‐1... por Liu, Xiao, Long, Chuyan, Xiong, Qinmei, Chen, Chen, Ma, Jianyong, Su, Yuhao, Hong, Kui
Publicado em 2020Texto -
16
Re: Is there a difference in the effect between the angiotensin‐converting enzyme inhibitor and angiotensin‐receptor blocker on the COVID‐19? por Liu, Xiao, Long, Chuyan, Xiong, Qinmei, Chen, Chen, Ma, Jianyong, Su, Yuhao, Hong, Kui
Publicado em 2020Texto -
17
Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies por Liu, Fuwei, Xu, Zixuan, Luo, Jun, Yu, Peng, Ma, Jianyong, Yuan, Ping, Zhu, Wengen
Publicado em 2021Texto -
18
Hydrogels for localized chemotherapy of liver cancer: a possible strategy for improved and safe liver cancer treatment por Ma, Jianyong, Wang, Bingzhu, Shao, Haibin, Zhang, Songou, Chen, Xiaozhen, Li, Feize, Liang, Wenqing
Publicado em 2022Texto -
19
Is there an exposure–effect relationship between body mass index and invasive mechanical ventilation, severity, and death in patients with COVID‐19? Evidence from an updated meta‐a... por Liu, Menglu, Deng, Chao, Yuan, Ping, Ma, Jianyong, Yu, Peng, Chen, Jie, Zhao, Yujie, Liu, Xiao
Publicado em 2020Texto -
20
Anxiety, depression, and medication adherence in Chinese patients with myocardial infarction in the absence of obstructive coronary artery disease por Liu, Menglu, Deng, Chao, Yuan, Ping, Ma, Jianyong, Yu, Peng, Chen, Jie, Zhao, Yujie, Liu, Xiao
Publicado em 2020Texto